These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17669686)

  • 21. Proximal left anterior descending coronary artery revascularization with drug-eluting stents.
    Guardado JH; Moreno R; Costa J; Perez-Viscayno MJ; Segura L; Alfonso F; Hernández R; Escaned J; Bañuelos C; Macaya C
    Arq Bras Cardiol; 2007 Feb; 88(2):159-66. PubMed ID: 17384832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
    Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
    Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis.
    Li JJ; Xu B; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Jul; 119(13):1059-64. PubMed ID: 16834923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ISR II study: a long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions.
    Commeau P; Barragan PT; Roquebert PO; Siméoni JB
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):158-62. PubMed ID: 16158397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
    Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
    Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the very long term (>1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosis.
    Ribamar Costa J; Sousa AG; Moreira A; Alves da Costa R; Cano MN; Maldonado G; Campos Neto C; Jardim C; Pavanello R; Sousa JE
    EuroIntervention; 2009 Sep; 5(4):448-53. PubMed ID: 19755332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of sirolimus-eluting stents for treatment of in-stent restenosis: long-term follow-up.
    Brambilla N; Ferrario M; Repetto A; Bramucci E; Angoli L; Canosi U; Rosso R; Ferlini M; Klersy C; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):699-705. PubMed ID: 17700399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sirolimus-eluting stent for in-stent restenosis treatment: single center results in an unselected study population].
    Bellandi F; Toso A; Maioli M; Leoncini M; Dabizzi RP
    Ital Heart J Suppl; 2005 Sep; 6(9):599-603. PubMed ID: 16281719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirolimus-eluting stents for the treatment of bare-metal in-stent restenosis: long-term clinical follow up.
    Sheiban I; Chiribiri A; Beninati S; Moretti C; Omede P; Sciuto F; Marra WG; Biondi-Zoccai G; Bollati M; Gambino A; Trevi GP
    J Invasive Cardiol; 2007 Apr; 19(4):174-80. PubMed ID: 17404403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome.
    Omar A; Torguson R; Kitabata H; Pendyala LK; Loh JP; Magalhaes MA; Satler LF; Suddath WO; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1053-60. PubMed ID: 24619969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
    Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
    J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Colombo A; Moses JW; Morice MC; Ludwig J; Holmes DR; Spanos V; Louvard Y; Desmedt B; Di Mario C; Leon MB
    Circulation; 2004 Mar; 109(10):1244-9. PubMed ID: 14981005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN Study.
    Brüggenjürgen B; McBride D; Bode C; Hamm CW; Kuck KH; Willich SN
    Herz; 2007 Dec; 32(8):650-5. PubMed ID: 18060612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.
    Zakliczynski M; Lekston A; Osuch M; Swierad M; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2859-61. PubMed ID: 18022002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stenting of unprotected left main coronary artery in patients with low preoperative risk of coronary artery bypass grafting.
    Dudek D; Heba G; Giszterowicz D; Rzeszutko Ł; Legutko J; Bartuś S; Chyrchel M; Dubiel JS
    Kardiol Pol; 2006 Sep; 64(9):929-36; discussion 937-8. PubMed ID: 17054024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.